Status:
UNKNOWN
Repetitive Transcranial Magnetic Stimulation for the Treatment of Freezing of Gait in Parkinson's Disease
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Parkinson Disease
Gait Disorders, Neurologic
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
Freezing of gait (FOG) is a common and devastating symptom in advanced stage Parkinson's disease (PD), which contributes to falls and disability. Unfortunately, there is no effective pharmacological t...
Eligibility Criteria
Inclusion
- Subjects fulfilled the diagnosis of idiopathic Parkinson's disease according to MDS-PD criteria
- Hoehn \& Yahr (H-Y) stage was 2 or 3
- All subjects had freezing of gait which was identified by FOGQ
Exclusion
- cognitive impairment (MMSE score\<22) or major depression (HAMD-24 score\>25)
- severe visual and/or haring impairment
- significant medical or psychiatric illnesses
- history of deep brain stimulation (DBS) surgery or pacemaker implantation. MRI cannot be performed in those patients
- current treatment with medication cannot be maintained during the study
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 14 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04431570
Start Date
June 15 2020
End Date
June 14 2022
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, China, 100730